OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,912,452 | -57.4% | 680,588 | -37.1% | 0.12% | -58.5% |
| Q3 2022 | $4,491,000 | +6.9% | 1,082,103 | +3.6% | 0.28% | +16.9% |
| Q2 2022 | $4,200,000 | -22.4% | 1,044,732 | -4.4% | 0.24% | +1.7% |
| Q1 2022 | $5,411,000 | -22.2% | 1,093,148 | +9.6% | 0.24% | -2.4% |
| Q4 2021 | $6,951,000 | +85.0% | 997,226 | +165.4% | 0.24% | +88.5% |
| Q3 2021 | $3,758,000 | -79.9% | 375,806 | -71.5% | 0.13% | -78.8% |
| Q2 2021 | $18,700,000 | -15.8% | 1,318,737 | -2.6% | 0.61% | -17.1% |
| Q1 2021 | $22,217,000 | -4.3% | 1,353,896 | +20.7% | 0.74% | -8.7% |
| Q4 2020 | $23,218,000 | – | 1,121,628 | – | 0.81% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |